ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 278

$1.53M Total Retail Price of All Prescriptions

Rank: 6 out of 278

560 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 18,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 916 730 1 2
FUROSEMIDE 781 674 2 6
HYDROCODONE-ACETAMINOPHEN 733 535 S3 3 1
SIMVASTATIN 693 502 4 4
METOPROLOL TARTRATE 641 517 5 9
LISINOPRIL 628 540 6 5
CARVEDILOL 540 400 7 23
POTASSIUM CHLORIDE 485 428 8 17
RANITIDINE HCL 443 299 9 27
OMEPRAZOLE 421 291 10 3
AMLODIPINE BESYLATE 403 338 11 7
QUETIAPINE FUMARATE 386 260 12 80
CITALOPRAM HBR 385 228 13 21
METFORMIN HCL 380 255 14 8
GABAPENTIN 354 246 15 12
DONEPEZIL HCL 333 257 16 29
WARFARIN SODIUM 316 299 17 11
TRAMADOL HCL 307 218 18 22
NAMENDA 300 210 19 48
CLOPIDOGREL 288 208 20 20
LEVETIRACETAM 285 139 21 106
RISPERIDONE 248 179 22 79
NEXIUM 236 136 23 14
PLAVIX 230 181 24 30
SERTRALINE HCL 229 185 25 25
NOVOLOG 216 141 26 122
OLANZAPINE 216 102 26 142
AZITHROMYCIN 216 171 26 39
GLIMEPIRIDE 216 167 26 28
TRAZODONE HCL 187 128 30 47
TAMSULOSIN HCL 187 155 30 32
DIVALPROEX SODIUM 185 122 32 103
CLOZAPINE 183 113 33 194
HYDRALAZINE HCL 183 137 33 91
ALENDRONATE SODIUM 171 107 35 51
LOSARTAN POTASSIUM 169 160 36 24
SEROQUEL 165 122 37 186
FLUOXETINE HCL 162 111 38 68
METOPROLOL SUCCINATE 162 141 38 10
PROAIR HFA 161 104 40 34
CYMBALTA 153 77 41 41
PAROXETINE HCL 151 133 42 57
CEPHALEXIN 151 114 42 92
OXYCODONE-ACETAMINOPHEN 150 88 S2 44 71
FINASTERIDE 150 122 44 104
HYDROCHLOROTHIAZIDE 146 133 46 15
CIPROFLOXACIN HCL 145 113 47 65
LANTUS 138 95 48 56
ISOSORBIDE MONONITRATE 135 120 49 205
CLONIDINE HCL 133 55 50 50
PRAVASTATIN SODIUM 129 118 51 16
MIRTAZAPINE 128 78 52 61
LACTULOSE 127 75 53 155
ATORVASTATIN CALCIUM 126 105 54 13
DIOVAN 122 81 55 43
PREDNISONE 121 89 56 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 91 57 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 112 58 31
HALOPERIDOL 110 73 59 283
BENZTROPINE MESYLATE 110 60 R 59 189
LEVEMIR 109 87 61 183
METHYLPREDNISOLONE 108 87 62 124
GEMFIBROZIL 107 80 63 118
AMITRIPTYLINE HCL 106 51 R 64 73
ALBUTEROL SULFATE 103 103 65 141
OXYCODONE HCL-ACETAMINOPHEN 101 38 S2 66 83
SPIRIVA 100 77 67 49
ATENOLOL 100 75 67 18
DILTIAZEM 24HR CD 99 57 69 95
DIGOXIN 99 78 69 40
ALLOPURINOL 98 89 71 38
SINGULAIR 95 80 72 60
ADVAIR DISKUS 95 71 72 45
CARBIDOPA-LEVODOPA 95 81 72 113
BUPROPION XL 91 50 75 223
AMOXICILLIN 90 66 76 100
CRESTOR 87 55 77 19
LYRICA 85 61 78 67
LAMOTRIGINE 83 34 79 175
NIASPAN 83 43 79 119
SUCRALFATE 82 29 81 149
ROPINIROLE HCL 81 66 82 69
BUSPIRONE HCL 81 72 82 178
FLUTICASONE PROPIONATE 81 72 82 44
PANTOPRAZOLE SODIUM 79 59 85 36
OXCARBAZEPINE 78 63 86 245
IBUPROFEN 78 43 86 89
KLOR-CON M20 78 62 86 42
BUMETANIDE 76 54 89 154
ZOLPIDEM TARTRATE 76 57 89 26
DICYCLOMINE HCL 71 55 91 241
ZIPRASIDONE HCL 69 44 92 199
ISOSORBIDE MONONITRATE ER 69 56 92 33
PROMETHAZINE HCL 67 19 R 94 106
AMLODIPINE BESYLATE-BENAZEPRIL 64 39 95 77
PROPAFENONE HCL 63 49 96 260
TERAZOSIN HCL 62 48 97 151
ALPRAZOLAM 60 49 98 128
HYDROXYZINE PAMOATE 60 35 R 98 212
AMOX TR-POTASSIUM CLAVULANATE 59 42 100 129
PEN NEEDLE 59 54 100 105
NAPROXEN 58 53 102 115
LANSOPRAZOLE 57 34 103 93
LEVOFLOXACIN 57 43 103 66
MONTELUKAST SODIUM 56 48 105 96
GEODON 55 40 106 275
INSULIN SYRINGE 55 42 106 72
HYDROCORTISONE 55 46 106 338
DILTIAZEM HCL 54 50 109 227
GLYBURIDE 54 14 R 109 88
NOVOLOG MIX 70-30 FLEXPEN 53 50 111 253
FLUCONAZOLE 52 31 112 165
NITROGLYCERIN PATCH 52 36 112 125
IPRATROPIUM BROMIDE 51 50 114 197
THEOPHYLLINE ANHYDROUS 50 50 115 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.